INTRODUCTION: The fractal analysis objectively quantifies the geometric complexity of structures in unitless measure index. We hypothesise it may reflect the degree of malignancy in glioblastoma multiformae (GBM). METHOD: A group of 33 patients with postoperative diagnosis of GBM were retrospectively enrolled into the study. Preoperative brain MR (T1-weighted post-gadolinium) were processed and analyzed to determine the average and maximum fractal dimension (F̄D and FDmax) of the inner and outer surface of the contrast enhancing part of the tumour. Box-count method and ImageJ 1.49 software were used. Corellations between fractal dimensions and: 1) demographics; 2) immunohistochemical characteristics; 3) progression free (PFS) and overal survival (OS); 4) tumour volume were determined by mean of nonparametric tests. RESULTS: There were 8 women and 25 men in the study group, mean age was 67 ± 10 years. Fractal analysis was possible to be perfomed in all cases with good inter-observer reproducibility (Kappa >0.80). The median FD̄ was 1.2550 (IQR 0.0897) and FDmax 1.3848 (IQR 0.1057). There was a statisticaly significant Spearman Rank correlation between fractal dimensions and Ki-67 index (-0.44 and -0.52 for FD̄ and FDmax respectively). Both FD̄ and FDmax were significantly (Fi2; p < 0.05) correlated with: age, tumor volume, PFS, OS, and Phosphohistone-H3 index but not with the expression of neurofilaments, p53, GFAP, EGFR and IDH-1. CONCLUSION: Fractal analysis of the preoperative MR images may pottentially act as an adjunct in determing the degree of malignancy and prognosis in GBM. Further studies on a wider cohort of patients are warranted.
. 2015 Nov 17;17(Suppl 8):viii6. doi: 10.1093/neuonc/nov284.27
PO31: FRACTAL ANALYSIS OF PREOPERATIVE IMAGING AS A TOOL FOR PREDICTING PROGNOSIS IN GLIOBLASTOMA MULTIFORMAE – PRELIMINARY RESULTS
Marcin Czyz
1, Hesham Radwan
1, Alexis M Demopoulos
1, Christopher G Filippi
1, Michael Schulder
1
Marcin Czyz
1Brain Tumor Center, North Shore University Hospital, NY, USA
Find articles by Marcin Czyz
Hesham Radwan
1Brain Tumor Center, North Shore University Hospital, NY, USA
Find articles by Hesham Radwan
Alexis M Demopoulos
1Brain Tumor Center, North Shore University Hospital, NY, USA
Find articles by Alexis M Demopoulos
Christopher G Filippi
1Brain Tumor Center, North Shore University Hospital, NY, USA
Find articles by Christopher G Filippi
Michael Schulder
1Brain Tumor Center, North Shore University Hospital, NY, USA
Find articles by Michael Schulder
1Brain Tumor Center, North Shore University Hospital, NY, USA
Issue date 2015 Nov.
Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2015.
PMCID: PMC4657679
